{"organizations": [], "uuid": "7980058b62e64dacdce3549230b54ee57f7e72c7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-alkermes-ceo-says-does-not-believe/brief-alkermes-ceo-says-does-not-believe-additional-trials-of-depression-drug-necessary-idUSFWN1RF09X", "country": "US", "domain_rank": 408, "title": "BRIEF-Alkermes CEO Says Does Not Believe Additional Trials Of Depression Drug Necessary", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-02T18:28:00.000+03:00", "replies_count": 0, "uuid": "7980058b62e64dacdce3549230b54ee57f7e72c7"}, "author": "", "url": "https://www.reuters.com/article/brief-alkermes-ceo-says-does-not-believe/brief-alkermes-ceo-says-does-not-believe-additional-trials-of-depression-drug-necessary-idUSFWN1RF09X", "ord_in_thread": 0, "title": "BRIEF-Alkermes CEO Says Does Not Believe Additional Trials Of Depression Drug Necessary", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "none"}, {"name": "depression drug necessary reuters", "sentiment": "none"}, {"name": "alkermes plc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 2, 2018 / 3:29 PM / in 27 minutes BRIEF-Alkermes CEO Says Does Not Believe Additional Trials Of Depression Drug Necessary Reuters Staff 1 Min Read \nApril 2 (Reuters) - Alkermes Plc: \n* CEO SAYS “WE DON’T BELIEVE ANY ADDITIONAL CLINICAL TRIALS ARE NECESSARY” ON CONF CALL WHEN ASKED ABOUT FDA’S DECISION ON ITS DEPRESSION DRUG‍​ Further company coverage:", "external_links": [], "published": "2018-04-02T18:28:00.000+03:00", "crawled": "2018-04-02T18:59:01.058+03:00", "highlightTitle": ""}